Cargando…

National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group

Reduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI–RIST). Different institutes adopt different approaches for the adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Hiroki, Soejima, Toshinori, Ishibashi, Naoya, Akiba, Takeshi, Hasegawa, Masatoshi, Isobe, Kouichi, Ito, Hitoshi, Imai, Michiko, Ejima, Yasuo, Hata, Masaharu, Sasai, Keisuke, Shimoda, Emiko, Oguchi, Masahiko, Akimoto, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805977/
https://www.ncbi.nlm.nih.gov/pubmed/31125077
http://dx.doi.org/10.1093/jrr/rrz028
_version_ 1783461521118986240
author Kawaguchi, Hiroki
Soejima, Toshinori
Ishibashi, Naoya
Akiba, Takeshi
Hasegawa, Masatoshi
Isobe, Kouichi
Ito, Hitoshi
Imai, Michiko
Ejima, Yasuo
Hata, Masaharu
Sasai, Keisuke
Shimoda, Emiko
Oguchi, Masahiko
Akimoto, Tetsuo
author_facet Kawaguchi, Hiroki
Soejima, Toshinori
Ishibashi, Naoya
Akiba, Takeshi
Hasegawa, Masatoshi
Isobe, Kouichi
Ito, Hitoshi
Imai, Michiko
Ejima, Yasuo
Hata, Masaharu
Sasai, Keisuke
Shimoda, Emiko
Oguchi, Masahiko
Akimoto, Tetsuo
author_sort Kawaguchi, Hiroki
collection PubMed
description Reduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI–RIST). Different institutes adopt different approaches for the administration of TBI–RIST, and since no study had previously investigated this issue, a survey of the TBI schedules in Japan was conducted. In October 2015, the Japanese Radiation Oncology Study Group initiated a national survey of TBI–RIST procedures conducted between 2010 and 2014. Of 186 institutions performing TBI, 90 (48%) responded to the survey, 78 of which performed TBI–RIST. Of 2488 patients who underwent TBI for malignant disease at these institutions, 1412 (56.8%) patients were treated for leukemia, 477 (19.2%) for malignant lymphoma, 453 (18.2) for myelodysplastic syndrome, 44 (1.8%) for multiple myeloma, and 102 (4.1%) for other malignant diseases. Further, 206 (52.0%) of 396 patients (a high proportion of patients) who underwent TBI for benign disease had aplastic anemia. The TBI–RIST equipment and treatment methods were similar to those used for myeloablative regimens. Routinely shielded organs included the lungs (43.6%), eyes (50.0%) and kidneys (10.2%). The ovaries (14.1%), thyroid (6.4%) and testicles (16.7%) were also frequently shielded, possibly reflecting an emphasis on shielding reproductive organs in children. TBI–RIST was performed more frequently than myeloablative conditioning in patients with benign disease. Genital and thyroid shielding were applied more frequently in patients treated with TBI–RIST than in patients treated with myeloablative conditioning. In conclusion, this study indicates the status of TBI–RIST in Japan and can assist future efforts to standardize TBI–RIST treatment methods and to design a future multicenter collaborative research study.
format Online
Article
Text
id pubmed-6805977
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68059772019-10-28 National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group Kawaguchi, Hiroki Soejima, Toshinori Ishibashi, Naoya Akiba, Takeshi Hasegawa, Masatoshi Isobe, Kouichi Ito, Hitoshi Imai, Michiko Ejima, Yasuo Hata, Masaharu Sasai, Keisuke Shimoda, Emiko Oguchi, Masahiko Akimoto, Tetsuo J Radiat Res Regular Papers Reduced-intensity stem cell transplantation (RIST) minimizes the adverse effects of traditional hematopoietic stem cell transplantation, and low-dose total-body irradiation (TBI) is administered over a short period prior to RIST (TBI–RIST). Different institutes adopt different approaches for the administration of TBI–RIST, and since no study had previously investigated this issue, a survey of the TBI schedules in Japan was conducted. In October 2015, the Japanese Radiation Oncology Study Group initiated a national survey of TBI–RIST procedures conducted between 2010 and 2014. Of 186 institutions performing TBI, 90 (48%) responded to the survey, 78 of which performed TBI–RIST. Of 2488 patients who underwent TBI for malignant disease at these institutions, 1412 (56.8%) patients were treated for leukemia, 477 (19.2%) for malignant lymphoma, 453 (18.2) for myelodysplastic syndrome, 44 (1.8%) for multiple myeloma, and 102 (4.1%) for other malignant diseases. Further, 206 (52.0%) of 396 patients (a high proportion of patients) who underwent TBI for benign disease had aplastic anemia. The TBI–RIST equipment and treatment methods were similar to those used for myeloablative regimens. Routinely shielded organs included the lungs (43.6%), eyes (50.0%) and kidneys (10.2%). The ovaries (14.1%), thyroid (6.4%) and testicles (16.7%) were also frequently shielded, possibly reflecting an emphasis on shielding reproductive organs in children. TBI–RIST was performed more frequently than myeloablative conditioning in patients with benign disease. Genital and thyroid shielding were applied more frequently in patients treated with TBI–RIST than in patients treated with myeloablative conditioning. In conclusion, this study indicates the status of TBI–RIST in Japan and can assist future efforts to standardize TBI–RIST treatment methods and to design a future multicenter collaborative research study. Oxford University Press 2019-10 2019-05-24 /pmc/articles/PMC6805977/ /pubmed/31125077 http://dx.doi.org/10.1093/jrr/rrz028 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular Papers
Kawaguchi, Hiroki
Soejima, Toshinori
Ishibashi, Naoya
Akiba, Takeshi
Hasegawa, Masatoshi
Isobe, Kouichi
Ito, Hitoshi
Imai, Michiko
Ejima, Yasuo
Hata, Masaharu
Sasai, Keisuke
Shimoda, Emiko
Oguchi, Masahiko
Akimoto, Tetsuo
National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group
title National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group
title_full National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group
title_fullStr National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group
title_full_unstemmed National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group
title_short National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group
title_sort national survey on total-body irradiation prior to reduced-intensity stem cell transplantation in japan: the japanese radiation oncology study group
topic Regular Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805977/
https://www.ncbi.nlm.nih.gov/pubmed/31125077
http://dx.doi.org/10.1093/jrr/rrz028
work_keys_str_mv AT kawaguchihiroki nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT soejimatoshinori nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT ishibashinaoya nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT akibatakeshi nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT hasegawamasatoshi nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT isobekouichi nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT itohitoshi nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT imaimichiko nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT ejimayasuo nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT hatamasaharu nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT sasaikeisuke nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT shimodaemiko nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT oguchimasahiko nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup
AT akimototetsuo nationalsurveyontotalbodyirradiationpriortoreducedintensitystemcelltransplantationinjapanthejapaneseradiationoncologystudygroup